Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
topic_facet:"COVID-19"
topic_facet:"Phase: Phase 1, Phase 2"
journalStr:"ClinicalTrials.gov"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (23)
1
A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) : A Phase 1/Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety, Tolerability and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Younger and Older Participants
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
SP16 as a Therapeutic for COVID-19 Induced ARDS : SP16 as a Therapeutic for SARS-CoV-2 Induced ARDS
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes : A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) : Plasma From Individuals Who Have Recovered From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection as Treatment for Acute COVID-19 Disease
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Efficacy of Ivermectin in COVID-19 : Efficacy and Safety of Ivermectin in Treatment of Mild to Moderate COVID-19 Infection: a Randomized ,Double Blind,Placebo,Controlled Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Convalescent Plasma vs. Standard Plasma for COVID-19 : Convalescent Plasma to Reduce Complications Associated With COVID-19 Infection: A Randomized Trial Comparing the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma vs. Standard Plasma in Hospitalized Patients With COVID- 19 Infection
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Use of UC-MSCs for COVID-19 Patients : Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study : Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Treatment of Covid-19 With a Herbal Compound, Xagrotin : Treatment of Early-Stage Covid-19 With a Herbal Compound, Xagrotin
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Study of AZD1222 for the Prevention of COVID-19 in Japan : A Phase I/II Randomized, Double-blind, Placebo-controlled Multicentre Study in Participants Aged 18 Years or Older to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Thema: COVID-19
Filter aufheben
Thema: Phase: Phase 1, Phase 2
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Medienart
23
Aufsätze
23
E-Artikel
23
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
23
610
COVID-19
Phase: Phase 1, Phase 2
23
Study Type: Interventional
13
Recruitment Status: Completed
8
Medical Condition: COVID-19
5
Recruitment Status: Recruiting
3
Recruitment Status: Terminated
3
Respiratory Distress Syndrome
2
Acute Lung Injury
2
Coronavirus Infections
2
Infections
2
Medical Condition: Covid19
2
Medical Condition: SARS-CoV-2 Infection
2
Recruitment Status: Not yet recruiting
2
Respiratory Distress Syndrome, Newborn
2
Syndrome
1
Communicable Diseases
1
Medical Condition: ARDS, Human, COVID-19
1
Medical Condition: COVID
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23
Englisch
Haven't found what you're looking for?
Wird geladen...